Preventing Amputations by Tailored Risk-based Intervention to Optimize Therapy
PATRIOT
1 other identifier
interventional
406
1 country
1
Brief Summary
The PATRIOT study will evaluate a risk-based personalized behavioral intervention to improve foot self-care, self-monitoring, and modifiable risks for amputation such as blood glucose, blood pressure and cholesterol in order to prevent diabetic foot ulcers in patients at higher than normal risk for amputation. This novel intervention aims to improve self-care and early detection of foot abnormalities in at-risk patients with diabetes and poor foot self-care using advanced behavioral approaches to target adherence to multiple health behaviors, including foot self-care, self-monitoring, medication adherence, dietary adherence, and physical activity simultaneously. If this promising behavioral theory-driven approach delivered using common technology (phone) to the patient at home can work in a setting where improvements in foot care are so urgent, it will be an important scientific contribution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes
Started Aug 2015
Longer than P75 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2015
CompletedFirst Posted
Study publicly available on registry
February 5, 2015
CompletedStudy Start
First participant enrolled
August 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedOctober 22, 2021
October 1, 2021
5.9 years
February 2, 2015
October 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ulcerative and non-ulcerative Foot lesions
High-resolution standard view digital photographs of the feet and footwear will be obtained and reviewed by the investigators blinded to group assignment, and a suspected ulcer or nonulcerative plantar lesion below the malleoli will be referred to a blinded (as to group assignment) adjudicators, all clinical experts. Lesions will be judged as absent/nonulcerative lesion/ulcer
12 months
Secondary Outcomes (10)
Foot care skills
12 months
Foot-care education
12 months
Medication adherence
12 months
Diet
12 months
Physical activity
12 months
- +5 more secondary outcomes
Study Arms (2)
Personalized Behavioral Intervention (PBI)
EXPERIMENTALThe PBI is a 12-month long integrated, multicomponent counseling and dermal thermometry intervention targeting foot self-care, foot self-monitoring, diet, medication and physical activity. The intervention is based on self-regulation theory, the Transtheoretical Model and
Current Best Practice (CBP)
PLACEBO COMPARATORThis group will receive all the enhancements that the VA has targeted to improve foot risk in diabetes and foot care, and will also receive counseling regarding preventing general health conditions.
Interventions
The PBI is based on self-regulation theory, the Transtheoretical Model and Prospect Theory, and will be delivered using Motivational Interviewing principles and the teach-back method. Participants will receive monthly calls targeting foot self-care, foot self-monitoring, diet, medication and physical activity for 6 months. Call/mailing frequency during the next 6 months will depend on adherence level to foot self-care and self-monitoring at 6 months.
CBP will include monthly calls from a counselor focusing on preventing conditions like colorectal cancer, flu, insomnia, vision problems, memory loss and oral disease for the first 6 months. Frequency of calls and mailings from counselors during the next 6 months will be determined by level of adherence to preventive strategies during the first 6 months.
Eligibility Criteria
You may qualify if:
- Adults with diabetes and PAVE score 1, 2 or 3, drug therapy for \> 6 months
- An available phone
- At least 2 primary care visits in the previous 1.5 years at the recruitment site
You may not qualify if:
- Patients with acute CVD events \< 3 months ago
- poor estimated short-term survival (\< 1 year)
- Recent major surgery (\< 3 months)
- Inability to exercise
- Prior toe or foot amputation
- Prior foot ulcer
- Temporary residence in the area
- Inability to provide consent will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
New York, New York, 10010, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sundar Natarajan, MD MSc
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2015
First Posted
February 5, 2015
Study Start
August 24, 2015
Primary Completion
June 30, 2021
Study Completion
September 30, 2021
Last Updated
October 22, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share